arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

GoodRx Holdings, Inc.

GDRX
$3.67 ▼ -0.06 (-1.61%) at close
Technology ·Services-Computer Processing & Data Preparation ·USServices-Computer Processing & Data Preparation
9 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
60
Health
Fair
Neutral
auto_awesome

Analytical Summary

GoodRx Holdings, Inc. shows mixed fundamentals. Consider comparing against peers in the Technology sector before making investment decisions.

Market Cap $1.3B
Dividend Yield
Revenue Growth 0.6%
Op. Margin 11.0%
ROIC 4.2%
FCF / Share $0.46
Trailing P/E 40.8x
Price / Book 2.1x
FCF Yield 12.6%
Debt / Equity 0.80
info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$796.85M
↑ +0.6%
Net Income Profit after all expenses
$30.44M
↑ +85.7%
Operating Margin Operating profit as % of sales
11.0%
↑ +32.1% 59th
FCF / Share Free cash flow per share
$0.46
↓ -2.6%
Long-Term Debt Long-term obligations
$495.00M
↓ -1.0%

Health Breakdown

Profitability
62
Returns
54
Financial Health
48
Cash Quality
96

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 31 quarters